271980 Stock Chart & Stats
₩9300.00
-₩210.00(-2.21%)
―
--
Day’s Range― - ―
52-Week Range₩8,810.00 - ₩19,290.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)20.63K
Market Cap
₩138.58B
Enterprise ValueN/A
Total Cash (Recent Filing)₩66.96B
Total Debt (Recent Filing)₩97.38B
Price to Earnings (P/E)4.8
Beta0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1975.29
Shares Outstanding14,704,872
10 Day Avg. Volume25,373
30 Day Avg. Volume20,631
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.06
Price to Sales (P/S)0.39
P/FCF Ratio-16.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
271980 FAQ
What was Jeil Pharmaceutical Co. Ltd.’s price range in the past 12 months?
Jeil Pharmaceutical Co. Ltd. lowest stock price was ₩8810.00 and its highest was ₩19290.00 in the past 12 months.
What is Jeil Pharmaceutical Co. Ltd.’s market cap?
Jeil Pharmaceutical Co. Ltd.’s market cap is ₩138.58B.
When is Jeil Pharmaceutical Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jeil Pharmaceutical Co. Ltd.’s earnings last quarter?
Jeil Pharmaceutical Co. Ltd. released its earnings results on May 15, 2026. The company reported -₩21.19 earnings per share for the quarter, missing the consensus estimate of N/A by -₩21.19.
Is Jeil Pharmaceutical Co. Ltd. overvalued?
According to Wall Street analysts Jeil Pharmaceutical Co. Ltd.’s price is currently Undervalued.
Does Jeil Pharmaceutical Co. Ltd. pay dividends?
Jeil Pharmaceutical Co. Ltd. does not currently pay dividends.
What is Jeil Pharmaceutical Co. Ltd.’s EPS estimate?
Jeil Pharmaceutical Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jeil Pharmaceutical Co. Ltd. have?
Jeil Pharmaceutical Co. Ltd. has 14,704,872 shares outstanding.
What happened to Jeil Pharmaceutical Co. Ltd.’s price movement after its last earnings report?
Jeil Pharmaceutical Co. Ltd. reported an EPS of -₩21.19 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.68%.
Which hedge fund is a major shareholder of Jeil Pharmaceutical Co. Ltd.?
Currently, no hedge funds are holding shares in KR:271980
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jeil Pharmaceutical Co. Ltd.
Primarily active within South Korea, Jeil Pharmaceutical Co.,Ltd dedicates itself to the development and supply of a broad spectrum of pharmaceutical goods. Its product offerings address numerous therapeutic categories, including antibiotics, gastrointestinal health, cardiovascular conditions, neuropsychiatric disorders, cancer (oncology), endocrine imbalances, urological issues, viral infections, and antihistamine remedies. Furthermore, the company extends its market reach globally, exporting its merchandise to roughly 40 nations across the ASEAN bloc, Central and South America, Africa, and other international destinations. Founded in 1959, Jeil Pharmaceutical Co.,Ltd maintains its headquarters in Seoul, South Korea.
Dong Wha Pharm Co., Ltd.
―
Samil Pharmaceutical Co., Ltd.
―
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
―
Daewon Pharmaceutical Co., Ltd
―
Kyongbo Pharmaceutical Co., Ltd.
―